This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sheps, S. G. Articles by Frohlich, E. D. Search for Related Content PubMed PubMed Citation Articles by Sheps, S. G. Articles by Frohlich, E. D. Pubmed/NCBI databases Medline Plus Health Information High Blood Pressure

(Hypertension. 1997;29:560-563.)
© 1997 American Heart Association, Inc.

Articles

Limited Echocardiography for Hypertensive Left Ventricular Hypertrophy

Sheldon G. Sheps; Edward D. Frohlich

Mayo Clinic, Rochester, Minn, and Ochsner Clinic, New Orleans, La.

Correspondence to Sheldon G. Sheps, MD, Division of Hypertension, Mayo Clinic, West 9, 200 First St SW, Rochester, MN 55905. E-mail ssheps@mayo.edu

Key Words: echocardiography • hypertrophy, left ventricular • technology assessment, biomedical

	Introduction

 
Echocardiographic assessment of left ventricular (LV) mass has provided the best noninvasive information to permit diagnostic, therapeutic, and prognostic assessment of hypertensive heart disease^{1 2 3 4 5 6 7} (Table 1). Reversal of hypertension-induced LV hypertrophy (LVH) occurs with all pharmacological (and some nonpharmacological) antihypertensive treatment, although few data are yet available to demonstrate that such reversal is associated with a reduced risk of LVH. However, one recent report suggested that patients who had changes of reversal of LVH (by electrocardiography [ECG]) were at substantially reduced risk compared with those who did not demonstrate diminished LVH.⁹ However, the cost of echocardiography has limited its utility in patients with hypertension. A less time-consuming and less-expensive LVH screening echocardiogram would be of great value; such a procedure is referred to as a limited echocardiogram.¹⁰

View this table: [in this window] [in a new window]   Table 1. Summary of Epidemiological Studies Relating Echocardiographic Left Ventricular Mass With Long-term Prognosis

	Technology

 
Echocardiography has been used as a standard procedure for the calculation of LV muscle mass for more than 25 years.¹¹ Primary measurements of LV dimensions are made according to American Society of Echocardiography standards using the leading edge method of interface recognition and by identifying end diastole and end systole at the QRS onset and nadir of posterior systolic motion of the interventricular septum.^{12 13 14} Adequate M-mode images for calculation of LV mass can be obtained in approximately 90% of patients in an experienced echo laboratory.^{15 16 17} Assessment of the degree of LVH should include measurements of the posterior wall and septal thickness and calculation of LV mass index. However, . . . [Full Text of this Article]

This article has been cited by other articles:

				C. M. Ferrario, J. Basile, W. Bestermann, E. Frohlich, M. Houston, D. T. Lackland, R. D. Smith, and D. L. Wise Review: The role of noninvasive hemodynamic monitoring in the evaluation and treatment of hypertension Therapeutic Advances in Cardiovascular Disease, December 1, 2007; 1(2): 113 - 118. [Abstract] [PDF]

				A. D. Waggoner Echocardiographic Assessment of Left Ventricular Structure in Hypertension and the Impact on Clinical Outcomes Journal of Diagnostic Medical Sonography, September 1, 2004; 20(5): 304 - 314. [Abstract] [PDF]

				J R T C Roelandt Ultrasound stethoscopy: a renaissance of the physical examination? Heart, September 1, 2003; 89(9): 971 - 973. [Full Text] [PDF]

				E C Vourvouri, L Y Koroleva, F J Ten Cate, D Poldermans, A F L Schinkel, R T van Domburg, W B Vletter, and J R T C Roelandt Clinical utility and cost effectiveness of a personal ultrasound imager for cardiac evaluation during consultation rounds in patients with suspected cardiac disease Heart, July 1, 2003; 89(7): 727 - 730. [Abstract] [Full Text] [PDF]

				E.C. Vourvouri, D. Poldermans, A.F.L. Schinkel, L.Y. Koroleva, F.B. Sozzi, G.E. Parharidis, J.J. Bax, and J.R.T.C. Roelandt Left ventricular hypertrophy screening using a hand-held ultrasound device Eur. Heart J., October 1, 2002; 23(19): 1516 - 1521. [Abstract] [Full Text] [PDF]

				R. S. Vasan, E. J. Benjamin, M. G. Larson, E. P. Leip, T. J. Wang, P. W. F. Wilson, and D. Levy Plasma Natriuretic Peptides for Community Screening for Left Ventricular Hypertrophy and Systolic Dysfunction: The Framingham Heart Study JAMA, September 11, 2002; 288(10): 1252 - 1259. [Abstract] [Full Text] [PDF]

				J.R.T.C Roelandt A personal ultrasound imager (ultrasound stethoscope). A revolution in the physical cardiac diagnosis! Eur. Heart J., April 1, 2002; 23(7): 523 - 527. [Full Text] [PDF]

				The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Arch Intern Med, November 24, 1997; 157(21): 2413 - 2446. [Abstract] [PDF]